Hot Off the Press – Neupro approved by FDA

Neupro (Rotigotine) is a dopaminergic agonist available in a skin patch.  Many people benefited from Neupro in the past but it was taken off the market by the FDA when it was noted that some of the medicine crystalized on the patch and therefore did not get absorbed well through the skin.

A patch delivery of medicine allows more continuously absorption of medicine throughout the day.  A small percentage of people cannot tolerate the patch  experience skin irritation or rash. Side effects of dopaminergic agonists are still a concern for this patch especially impulsivity control problems, sedation, hallucinations, nausea, and low blood pressure.

Learn more about dopamine agonists


Leave a comment

Filed under Hot Off the Press!, Parkinson's Medical therapy

Comment on this post

Please log in using one of these methods to post your comment: Logo

You are commenting using your account. Log Out /  Change )

Google+ photo

You are commenting using your Google+ account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s